Biotech news
Refine search
Asia-Pacific
Yoshinori Ohsumi was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 10 November 2017
Biotech
Michael Salzmann was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 10 November 2017
Americas
David Tomko was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports. 10 November 2017
Pharma
Marcus Dalton was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the legal section, as LSIPR reports. 10 November 2017
Americas
Steve Bossone was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the legal section, as LSIPR reports. 10 November 2017
Americas
Andrea Borucki was selected in the LSIPR 50 2017 publication for her influence on the life sciences industry. She featured in the legal section, as LSIPR reports. 10 November 2017
Americas
Eduardo Andretto was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the legal section, as LSIPR reports. 10 November 2017
Biotech
In September 2016, the German Federal Supreme Court decided a patent case that could have a major impact on companies working in the diagnostics field. Joachim Wachenfeld of Vossius & Partner reports. 9 November 2017
Americas
Past successes by trailblazers in other biotechnological fields could assist potential patentees navigate legal bumps along the road to IP protection for CRISPR-related inventions, as Patricia Carson and Ashley Ross of Kirkland & Ellis describe. 9 November 2017
Americas
Cindy Ahn, a former counsel at Schiff Hardin, has joined private equity firm Longford Capital to help handle demand for litigation finance among life sciences and biotech firms. 6 November 2017